All In Biotech

Drug Trial Radar · NCT00101725

A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of TRN 002 (Crofelemer) for the Symptomatic Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (d-IBS)

Last checked: Nov 19, 2026Latest source record: Nov 25, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 245 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

245

Actual

Start

Dec 2004

Primary completion

Nov 2005

Study completion Nov 2005

Sponsor

Lead sponsor
Bausch Health Americas, Inc.Industry
Sponsor type
Industry
First posted
Jan 13, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is designed to evaluate the safety and effectiveness of an investigational drug, TRN-002 (crofelemer) to relieve the symptoms of diarrhea-predominant irritable bowel syndrome (IBS).

Conditions

  • Irritable Bowel Syndrome
  • Colonic Diseases
  • Diarrhea
  • Gastrointestinal Disease

Interventions

  • crofelemerDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To assess the safety of TRN-002 when administered twice daily for 12 consecutive weeks.

Locations

29 sites in 1 country. Site status is shown where the registry gives one.

  • Clinical Research Associates

    Huntsville, Alabama

  • Radiant Research Phoenix Southeast

    Chandler, Arizona

  • Arkansas Gastroenterology

    North Little Rock, Arkansas

  • AGMG Clinical Research Institute

    Anaheim, California

  • Community Clinical Trials

    Orange, California

  • AGMG Clinical Research

    Orange, California

  • Institute of Healthcare Assessment, Inc.

    San Diego, California

  • Washington Gastroenterology

    Washington D.C., District of Columbia

  • Consultants for Clinical Research of South Florida

    Boynton Beach, Florida

  • University Clinical Research DeLand

    DeLand, Florida

  • nTouch Research

    Peoria, Illinois

  • Synergy Medical Education Alliance

    Saginaw, Michigan

  • CRC of Jakson

    Jackson, Mississippi

  • Mercy Medical Group

    St Louis, Missouri

  • Tobey Village Office Park

    Pittsford, New York

  • LeBauer Research Associates, PA

    Greensboro, North Carolina

  • Medoff Medical / Vital Research

    Greensboro, North Carolina

  • Hanover Medical Specialists, PA

    Wilmington, North Carolina

  • Piedmont Medical Research Assoc., Inc.

    Winston-Salem, North Carolina

  • Consultants for Clinical Research

    Cincinnati, Ohio

  • Radient Research

    Columbus, Ohio

  • Grandview Medical Research, Inc

    Sellersville, Pennsylvania

  • Anderson Gastroenterology

    Anderson, South Carolina

  • TriCities Medical Research

    Bristol, Tennessee

  • ClinSearch

    Chattanooga, Tennessee

  • Jackson Clinic

    Jackson, Tennessee

  • Memphis Gastroenterology

    Memphis, Tennessee

  • Radiant Research Dallas-North

    Dallas, Texas

  • Tacoma Digestive Disease Research Center

    Tacoma, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.